Los puntos clave no están disponibles para este artículo en este momento.
Antimicrobial resistance (AMR) poses a significant threat to global health, complicating the treatment of infectious diseases and leading to increased morbidity and mortality. Innovative drug delivery methods are emerging as critical strategies to combat AMR by enhancing the efficacy of existing antibiotics and facilitating the development of new therapeutic approaches. This paper explores the role of novel drug delivery systems in addressing AMR challenges. One of the primary approaches is the development of targeted drug delivery systems that improve the precision of antibiotic therapy. Nanotechnology has revolutionized this field, enabling the creation of nanoparticles and nanocarriers that can deliver drugs directly to infection sites, reducing systemic side effects and enhancing drug concentration at the target. These advanced delivery systems can be engineered to release antibiotics in a controlled manner, overcoming bacterial resistance mechanisms and minimizing the likelihood of resistance development. Another promising strategy involves the use of combination therapies delivered through innovative methods. By combining antibiotics with adjuvants or resistance-modifying agents, these systems can counteract resistance mechanisms and restore the effectiveness of existing drugs. For instance, drug delivery platforms that co-deliver antibiotics with inhibitors of bacterial efflux pumps or biofilm formation can enhance the treatment of resistant infections. The integration of smart drug delivery systems, which respond to environmental stimuli such as pH changes or specific bacterial enzymes, offers additional advantages. These systems can release antibiotics only in the presence of resistant bacteria, thereby reducing the overall exposure of bacteria to antibiotics and decreasing the risk of resistance. Innovative drug delivery methods also include the development of long-acting formulations and implants that provide sustained release of antibiotics over extended periods. Such systems reduce the frequency of dosing, improve patient adherence, and ensure consistent therapeutic levels, which are crucial for managing chronic infections and preventing resistance. In conclusion, innovative drug delivery methods are pivotal in the fight against AMR. By enhancing drug targeting, combining therapies, and utilizing smart and sustained-release systems, these approaches offer promising solutions to improve antibiotic efficacy and curb resistance. Continued research and development in this area are essential for advancing therapeutic strategies and ensuring effective management of infectious diseases in the face of rising antimicrobial resistance. Keywords: Innovative, Drug Delivery Methods, Combating, Antimicrobial, Resistance.
Nwankwo et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: